The European Commission (EC) has already approved Valneva’s chikungunya vaccine Ixchiq for use in individuals aged 18 years ...
Vaccine specialist Valneva has picked up an approval from the MHRA, as well. The agency approved the company's chikungunya vaccine, Ixchiq, for use in people 18 years of age and older. Late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback